Robotic interval debulking surgery for advanced epithelial ovarian cancer: current challenge or future direction? A systematic review. J Robot Surg. 2020 Oct 09;: Authors: Psomiadou V, Prodromidou A, Fotiou A, Lekka S, Iavazzo C Abstract We evaluated the effectiveness, safety and efficacy of robotic interval debulking surgery (IDS) in advanced epithelial ovarian cancer (EOC) treated with neoadjuvant chemotherapy (NACT). We conducted a...
Sun Oct 11, 2020 13:46
Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials. Jpn J Clin Oncol. 2020 Oct 10;: Authors: Nara S, Esaki M, Ban D, Takamoto T, Shimada K, Ioka T, Okusaka T, Ishii H, Furuse J Abstract Cancer originating in the biliary tract can be classified as bile duct cancer (cholangiocarcinoma), gallbladder cancer, or ampullary cancer. Bile duct cancer is further divided to intrahepatic, perihilar and distal bile...
Sun Oct 11, 2020 13:46
Feasibility of upfront mobile money transfers for transportation reimbursement to promote retention among patients receiving lymphoma treatment in Malawi. Int Health. 2020 Oct 09;: Authors: Ellis GK, Manda A, Topazian H, Stanley CC, Seguin R, Minnick CE, Tewete B, Mtangwanika A, Chawinga M, Chiyoyola S, Chikasema M, Salima A, Kimani S, Kasonkanji E, Mithi V, Kaimila B, Painschab MS, Gopal S, Westmoreland KD Abstract BACKGROUND: Cancer...
Sun Oct 11, 2020 13:46
Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets. Commun Biol. 2020 Oct 09;3(1):564 Authors: van de Ven K, de Heij F, van Dijken H, Ferreira JA, de Jonge J Abstract Traditional influenza vaccines primarily induce a narrow antibody response that offers no protection against heterosubtypic infections. Murine studies have shown that T cells can protect against a broad range of influenza...
Sun Oct 11, 2020 13:46
Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome. Signal Transduct Target Ther. 2019 Oct 12;4(1):41 Authors: Zhang Z, Tang H, Chen P, Xie H, Tao Y Abstract The trillions of microorganisms in the gut microbiome have attracted much attention recently owing to their sophisticated and widespread impacts on numerous aspects of host pathophysiology. Remarkable progress in large-scale...
Sun Oct 11, 2020 13:46
Evolving impact of long-term survival results on metastatic melanoma treatment. J Immunother Cancer. 2020 Oct;8(2): Authors: Michielin O, Atkins MB, Koon HB, Dummer R, Ascierto PA Abstract Melanoma treatment has been revolutionized over the past decade. Long-term results with immuno-oncology (I-O) agents and targeted therapies are providing evidence of durable survival for a substantial number of patients. These results have prompted consideration...
Sun Oct 11, 2020 13:46
Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists. Urol Oncol. 2020 Oct 06;: Authors: Rosenzweig B, Bex A, Dotan ZA, Frydenberg M, Klotz L, Lotan Y, Schulman CC, Tsaur I, Ramon J Abstract OBJECTIVE: Ad-hoc guidelines for managing the COVID-19 pandemic are published worldwide. We investigated international applications of such policies...
Sun Oct 11, 2020 13:46
Cerium Oxide Nanoparticles (Nanoceria): Hopes in Soft Tissue Engineering. Molecules. 2020 Oct 06;25(19): Authors: Sadidi H, Hooshmand S, Ahmadabadi A, Javad Hosseini S, Baino F, Vatanpour M, Kargozar S Abstract Several biocompatible materials have been applied for managing soft tissue lesions; cerium oxide nanoparticles (CNPs, or nanoceria) are among the most promising candidates due to their outstanding properties, including antioxidant,...
Sun Oct 11, 2020 13:46
24 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results: Future Oncology These pubmed results were generated on 2020/10/10PubMed comprises more than millions of citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Sat Oct 10, 2020 14:49
24 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results: Future Oncology These pubmed results were generated on 2020/10/10PubMed comprises more than millions of citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Sat Oct 10, 2020 13:48
Experiences of awake surgery in non-tumoural epilepsy in eloquent localizations. Clin Neurol Neurosurg. 2020 Sep 25;199:106251 Authors: Vigren P, Eriksson M, Duffau H, Wretman A, Lindehammar H, Milos P, Richter J, Karlsson T, Gauffin H Abstract BACKGROUND: Whilst modern awake intraoperative mapping has been widely accepted and implemented in the last decades in neuro-oncology, sparse reports have been published on the safety and efficiency...
Fri Oct 09, 2020 13:42
Anticipating the future of the child and family in pediatric palliative care: a qualitative study into the perspectives of parents and healthcare professionals. Eur J Pediatr. 2020 Oct 08;: Authors: Verberne LM, Fahner JC, Sondaal SFV, Schouten-van Meeteren AYN, de Kruiff CC, van Delden JJM, Kars MC Abstract Preparing for future scenarios in pediatric palliative care is perceived as complex and challenging by both families and healthcare...
Fri Oct 09, 2020 13:42
MyPref: pilot study of a novel communication and decision-making tool for adolescents and young adults with advanced cancer. Support Care Cancer. 2020 Oct 08;: Authors: Snaman JM, Helton G, Holder RL, Wittenberg E, Revette A, Tulsky JA, Baker JN, Wolfe J Abstract PURPOSE: Adolescents and young adults (AYAs) with cancer report feeling ill-informed about their cancer treatment options. Tools are needed to inform AYAs about treatment choices...
Fri Oct 09, 2020 13:42
Producing a Beam Model of the Varian ProBeam Proton Therapy System using TOPAS Monte Carlo Toolkit. Med Phys. 2020 Oct 08;: Authors: Rahman M, Bruza P, Lin Y, Gladstone DJ, Pogue BW, Zhang R Abstract PURPOSE: A Geant4-based TOPAS Monte Carlo toolkit was utilized to model a Varian ProBeam proton therapy system, with the aim of providing an independent computational platform for validating advanced dosimetric methods. MATERIALS...
Fri Oct 09, 2020 13:42
Poor Psychosocial Well-Being in the First Year-and-a-Half After Losing a Parent to Cancer - A Longitudinal Study Among Young Adults Participating in Support Groups. J Soc Work End Life Palliat Care. 2020 Oct 08;:1-16 Authors: Lundberg T, Forinder U, Olsson M, Fürst CJ, Årestedt K, Alvariza A Abstract The purpose of this study was to investigate variations in psychosocial well-being over time among young adults who participated in a support...
Fri Oct 09, 2020 13:42
Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib. Clin Pharmacokinet. 2020 Oct 08;: Authors: Groenland SL, Martínez-Chávez A, van Dongen MGJ, Beijnen JH, Schinkel AH, Huitema ADR, Steeghs N Abstract Palbociclib, ribociclib, and abemaciclib are inhibitors of the cyclin-dependent kinases 4 and 6 approved for the treatment of locally advanced or metastatic...
Fri Oct 09, 2020 13:42
Targeted Therapies in the Management of Well-Differentiated Digestive and Lung Neuroendocrine Neoplasms. Curr Treat Options Oncol. 2020 Oct 07;21(12):96 Authors: Vijayvergia N, Dasari A Abstract OPINION STATEMENT: Ongoing advances in our understanding of neuroendocrine tumor (NET) biology, genetics, and immunology, will continue to expand the availability of targeted therapies, thus improving the outcomes of patients. Well-differentiated...
Fri Oct 09, 2020 13:42
Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer. BMC Cancer. 2020 Oct 07;20(1):970 Authors: Hoover AA, Hufnagel DH, Harris W, Bullock K, Glass EB, Liu E, Barham W, Crispens MA, Khabele D, Giorgio TD, Wilson AJ, Yull FE Abstract BACKGROUND: New treatment options for ovarian cancer are urgently required. Tumor-associated macrophages...
Fri Oct 09, 2020 13:42
Exploratory analysis of the platelet-to-lymphocyte ratio prognostic value in the adjuvant renal cell cancer setting. Future Oncol. 2020 Oct 08;: Authors: Patel A, Ravaud A, Motzer RJ, Pantuck AJ, Staehler M, Escudier B, Martini JF, Lechuga M, Lin X, George DJ Abstract Aim: To examine the prognostic value of the platelet-to-lymphocyte ratio (PLR) in the adjuvant renal cell carcinoma setting. Materials & methods: Patients received adjuvant...
Fri Oct 09, 2020 13:42
Zanubrutinib: a new BTK inhibitor for treatment of relapsed/refractory mantle cell lymphoma. Drugs Today (Barc). 2020 Aug;56(8):531-539 Authors: Weaver AN, Jimeno A Abstract Mantle cell lymphoma (MCL) has historically been an aggressive disease with poor long-term survival. In the last decade, Bruton tyrosine kinase (BTK) inhibition has emerged as a new treatment strategy for MCL, especially in the relapsed/refractory (r/r) setting. Zanubrutinib,...
Fri Oct 09, 2020 13:42
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου